Statement re press speculation

By

Regulatory News | 28 Jun, 2024

Updated : 10:17

RNS Number : 3648U
Tavistock Investments PLC
28 June 2024
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation. With the publication of this announcement, this information is now considered to be in the public domain.

 

 

Tavistock Investments plc

("Tavistock", the "Company" or the "Group")

 

Statement re press speculation

28 June 2024

 

The Board of Tavistock notes the recent media speculation and confirms that it is considering a number of potential transactions including a possible disposal of part of the Group's business to Saltus, a financial planning and investment management services group. There can be no guarantee that such a transaction will be concluded, and the Board will only proceed with such a transaction if it considers it to be in the best interests of the Company and its shareholders.

 

The Company will make further announcements if and when appropriate.

 

For further information:

 

Oliver Cooke

Brian Raven

      Tel: 01753 867000

 



Allenby Capital Limited

(Nominated adviser and broker to Tavistock)

Corporate Finance:

Nick Naylor, Liz Kirchner, Daniel Dearden-Williams

Sales and Corporate Broking:

Tony Quirke

 

Tel: 020 3328 5656

 

 

 

 

 


Powerscourt

Gilly Lock

Justin Griffiths 

 

Tel: 07711 380 007

       020 7250 1446

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCUWAKRSVUNURR

Last news